H. Erin Xie - 30 Jan 2026 Form 4 Insider Report for BlackRock Health Sciences Term Trust (BMEZ)

Role
Portfolio Manager
Signature
/s/ Gladys Chang as Attorney-in-Fact
Issuer symbol
BMEZ
Transactions as of
30 Jan 2026
Net transactions value
-$123,441
Form type
4
Filing time
03 Feb 2026, 16:22:47 UTC
Previous filing
04 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Xie H Erin Portfolio Manager 50 HUDSON YARDS, NEW YORK /s/ Gladys Chang as Attorney-in-Fact 03 Feb 2026 0001320932

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMEZ Common Stock Options Exercise +25,676 25,676 30 Jan 2026 Direct F1, F2, F3, F4
transaction BMEZ Common Stock Disposed to Issuer $390,536 -25,676 -100% $15.21 0 30 Jan 2026 Direct F1, F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMEZ Phantom Shares Award $267,095 +17,560 $15.21 17,560 30 Jan 2026 Common Stock 17,560 Direct F1, F5
transaction BMEZ Phantom Shares Options Exercise -8,915 -33% 17,831 30 Jan 2026 Common Stock 8,915 Direct F1, F2
transaction BMEZ Phantom Shares Options Exercise -8,862 -50% 8,862 30 Jan 2026 Common Stock 8,862 Direct F1, F3
transaction BMEZ Phantom Shares Options Exercise -7,899 -100% 0 30 Jan 2026 Common Stock 7,899 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash.
F2 As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
F3 As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
F4 As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
F5 These phantom shares vest in equal installments on each of the first three anniversaries of the award.